Drug Type Small molecule drug |
Synonyms Glycopyrrolate/rivastigmine |
Target |
Mechanism AChE inhibitors(Acetylcholinesterase inhibitors), mAChRs antagonists(Muscarinic acetylcholine receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H28BrNO3 |
InChIKeyVPNYRYCIDCJBOM-HPUDQCTASA-M |
CAS Registry51186-83-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 1 | US | - | |
Alzheimer Disease | Phase 1 | - | - | |
Alzheimer Disease | Phase 1 | - | - | |
Lewy Body Disease | Phase 1 | - | - | |
Lewy Body Disease | Phase 1 | US | - | |
Lewy Body Disease | Phase 1 | - | - |
Not Applicable | - | - | isahqirowc(dljjvjcfew) = otkoqvrcbu gklktsbwid (vzncnlrcbj ) | - | 01 Jul 2013 | ||
isahqirowc(dljjvjcfew) = xhsounpgqt gklktsbwid (vzncnlrcbj ) |